Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development

The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers of medicine 2011-06, Vol.5 (2), p.171-177
Hauptverfasser: Bian, Zhaoxiang, Liu, Baoyan, Moher, David, Wu, Taixiang, Li, Youping, Shang, Hongcai, Cheng, Chungwah
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 177
container_issue 2
container_start_page 171
container_title Frontiers of medicine
container_volume 5
creator Bian, Zhaoxiang
Liu, Baoyan
Moher, David
Wu, Taixiang
Li, Youping
Shang, Hongcai
Cheng, Chungwah
description The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.
doi_str_mv 10.1007/s11684-011-0132-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_873494750</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>873494750</sourcerecordid><originalsourceid>FETCH-LOGICAL-c335z-db5e3bd92f0f79022756f3c30a9cbaebe4191becde211487b507a84040fa6d453</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxU1paEKSD9BLEfTQ9uBUkiXb6q2Y_oPQhTY9C9ka7Sp4LXckF7qXfvVqcRpKDhEIDdLvPTHziuI5o1eM0uZtZKxuRUkZy7vi5eFJccapkiXlXD69r1lzWlzGeEvzEjVrlHpWnHJWK1lzflb86cIUw-itSWBJTGayBm0kwRGEOWDy05Yk9GaM5HW3-fp98-3mDXEB86WxPvkwmZF0Oz9BBLIH64dcviPDgghTItGnxRwpkp2JW9KCQCz8gjHM-wxcFCcue8Pl3Xle_Pj44ab7XF5vPn3p3l-XQ1XJQ2l7CVVvFXfUNSp32MjaVUNFjRp6Az0IplgPgwXOmGibXtLGtIIK6kxthazOi1er74zh5wIx6b2PA4yjmSAsUbdNJZRoJM3kywfkbVgwdxk1U-I4c0VFpthKDRhiRHB6Rr83-Fszqo_56DUfnfPRx3z0IWte3DkvfZ7UveJfGhngKxDz07QF_O_rR1zbVbTz2x0g2BkhRu0wTMkDPib9C4h6rxk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1941684904</pqid></control><display><type>article</type><title>Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Bian, Zhaoxiang ; Liu, Baoyan ; Moher, David ; Wu, Taixiang ; Li, Youping ; Shang, Hongcai ; Cheng, Chungwah</creator><creatorcontrib>Bian, Zhaoxiang ; Liu, Baoyan ; Moher, David ; Wu, Taixiang ; Li, Youping ; Shang, Hongcai ; Cheng, Chungwah</creatorcontrib><description>The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.</description><identifier>ISSN: 2095-0217</identifier><identifier>EISSN: 2095-0225</identifier><identifier>DOI: 10.1007/s11684-011-0132-z</identifier><identifier>PMID: 21695622</identifier><language>eng</language><publisher>Heidelberg: Higher Education Press</publisher><subject>Chinese medicine ; Compilation &amp; review ; CONSORT for TCM ; future development ; Guidelines as Topic ; Humans ; Medicine ; Medicine &amp; Public Health ; Medicine, Chinese Traditional - standards ; Randomized Controlled Trials as Topic - standards ; Report writing ; reporting standards ; Research Report - standards ; Review</subject><ispartof>Frontiers of medicine, 2011-06, Vol.5 (2), p.171-177</ispartof><rights>Copyright reserved, 2014, Higher Education Press and Springer-Verlag Berlin Heidelberg</rights><rights>Higher Education Press and Springer-Verlag Berlin Heidelberg 2011</rights><rights>Frontiers of Medicine is a copyright of Springer, 2011.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c335z-db5e3bd92f0f79022756f3c30a9cbaebe4191becde211487b507a84040fa6d453</citedby><cites>FETCH-LOGICAL-c335z-db5e3bd92f0f79022756f3c30a9cbaebe4191becde211487b507a84040fa6d453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11684-011-0132-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11684-011-0132-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21695622$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bian, Zhaoxiang</creatorcontrib><creatorcontrib>Liu, Baoyan</creatorcontrib><creatorcontrib>Moher, David</creatorcontrib><creatorcontrib>Wu, Taixiang</creatorcontrib><creatorcontrib>Li, Youping</creatorcontrib><creatorcontrib>Shang, Hongcai</creatorcontrib><creatorcontrib>Cheng, Chungwah</creatorcontrib><title>Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development</title><title>Frontiers of medicine</title><addtitle>Front Med</addtitle><addtitle>Front. Med</addtitle><addtitle>Front Med</addtitle><description>The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.</description><subject>Chinese medicine</subject><subject>Compilation &amp; review</subject><subject>CONSORT for TCM</subject><subject>future development</subject><subject>Guidelines as Topic</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Medicine, Chinese Traditional - standards</subject><subject>Randomized Controlled Trials as Topic - standards</subject><subject>Report writing</subject><subject>reporting standards</subject><subject>Research Report - standards</subject><subject>Review</subject><issn>2095-0217</issn><issn>2095-0225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU9r3DAQxU1paEKSD9BLEfTQ9uBUkiXb6q2Y_oPQhTY9C9ka7Sp4LXckF7qXfvVqcRpKDhEIDdLvPTHziuI5o1eM0uZtZKxuRUkZy7vi5eFJccapkiXlXD69r1lzWlzGeEvzEjVrlHpWnHJWK1lzflb86cIUw-itSWBJTGayBm0kwRGEOWDy05Yk9GaM5HW3-fp98-3mDXEB86WxPvkwmZF0Oz9BBLIH64dcviPDgghTItGnxRwpkp2JW9KCQCz8gjHM-wxcFCcue8Pl3Xle_Pj44ab7XF5vPn3p3l-XQ1XJQ2l7CVVvFXfUNSp32MjaVUNFjRp6Az0IplgPgwXOmGibXtLGtIIK6kxthazOi1er74zh5wIx6b2PA4yjmSAsUbdNJZRoJM3kywfkbVgwdxk1U-I4c0VFpthKDRhiRHB6Rr83-Fszqo_56DUfnfPRx3z0IWte3DkvfZ7UveJfGhngKxDz07QF_O_rR1zbVbTz2x0g2BkhRu0wTMkDPib9C4h6rxk</recordid><startdate>20110601</startdate><enddate>20110601</enddate><creator>Bian, Zhaoxiang</creator><creator>Liu, Baoyan</creator><creator>Moher, David</creator><creator>Wu, Taixiang</creator><creator>Li, Youping</creator><creator>Shang, Hongcai</creator><creator>Cheng, Chungwah</creator><general>Higher Education Press</general><general>SP Higher Education Press</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20110601</creationdate><title>Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development</title><author>Bian, Zhaoxiang ; Liu, Baoyan ; Moher, David ; Wu, Taixiang ; Li, Youping ; Shang, Hongcai ; Cheng, Chungwah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c335z-db5e3bd92f0f79022756f3c30a9cbaebe4191becde211487b507a84040fa6d453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Chinese medicine</topic><topic>Compilation &amp; review</topic><topic>CONSORT for TCM</topic><topic>future development</topic><topic>Guidelines as Topic</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Medicine, Chinese Traditional - standards</topic><topic>Randomized Controlled Trials as Topic - standards</topic><topic>Report writing</topic><topic>reporting standards</topic><topic>Research Report - standards</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bian, Zhaoxiang</creatorcontrib><creatorcontrib>Liu, Baoyan</creatorcontrib><creatorcontrib>Moher, David</creatorcontrib><creatorcontrib>Wu, Taixiang</creatorcontrib><creatorcontrib>Li, Youping</creatorcontrib><creatorcontrib>Shang, Hongcai</creatorcontrib><creatorcontrib>Cheng, Chungwah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Frontiers of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bian, Zhaoxiang</au><au>Liu, Baoyan</au><au>Moher, David</au><au>Wu, Taixiang</au><au>Li, Youping</au><au>Shang, Hongcai</au><au>Cheng, Chungwah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development</atitle><jtitle>Frontiers of medicine</jtitle><stitle>Front Med</stitle><stitle>Front. Med</stitle><addtitle>Front Med</addtitle><date>2011-06-01</date><risdate>2011</risdate><volume>5</volume><issue>2</issue><spage>171</spage><epage>177</epage><pages>171-177</pages><issn>2095-0217</issn><eissn>2095-0225</eissn><abstract>The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.</abstract><cop>Heidelberg</cop><pub>Higher Education Press</pub><pmid>21695622</pmid><doi>10.1007/s11684-011-0132-z</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2095-0217
ispartof Frontiers of medicine, 2011-06, Vol.5 (2), p.171-177
issn 2095-0217
2095-0225
language eng
recordid cdi_proquest_miscellaneous_873494750
source MEDLINE; SpringerNature Journals
subjects Chinese medicine
Compilation & review
CONSORT for TCM
future development
Guidelines as Topic
Humans
Medicine
Medicine & Public Health
Medicine, Chinese Traditional - standards
Randomized Controlled Trials as Topic - standards
Report writing
reporting standards
Research Report - standards
Review
title Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T13%3A55%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consolidated%20standards%20of%20reporting%20trials%20(CONSORT)%20for%20traditional%20Chinese%20medicine:%20current%20situation%20and%20future%20development&rft.jtitle=Frontiers%20of%20medicine&rft.au=Bian,%20Zhaoxiang&rft.date=2011-06-01&rft.volume=5&rft.issue=2&rft.spage=171&rft.epage=177&rft.pages=171-177&rft.issn=2095-0217&rft.eissn=2095-0225&rft_id=info:doi/10.1007/s11684-011-0132-z&rft_dat=%3Cproquest_cross%3E873494750%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1941684904&rft_id=info:pmid/21695622&rfr_iscdi=true